Table of Contents Author Guidelines Submit a Manuscript
Advances in Bioinformatics
Volume 2014, Article ID 850628, 12 pages
http://dx.doi.org/10.1155/2014/850628
Research Article

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor

1Biology Doctoral Program, Faculty of Science, Brawijaya University, Malang 65141, Indonesia
2Academic of Pharmacy and Food Analysis, Putra Indonesia Malang, Malang 65123, Indonesia
3Chemistry Department, Faculty of Science, Brawijaya University, Malang 65123, Indonesia
4Medicine Pharmacology, Faculty of Medicine, Brawijaya University, Malang 65141, Indonesia
5Graduate Life Science School, Ritsumeikan University, Biwako Kutsasu Campus, Kutsasu, Shiga 525-8577, Japan
6Biology Department, Faculty of Science, Brawijaya University, Malang 65141, Indonesia

Received 5 May 2014; Revised 7 July 2014; Accepted 8 July 2014; Published 17 November 2014

Academic Editor: Huixiao Hong

Copyright © 2014 Sentot Joko Raharjo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Raharjo and R. Retnowati, “Yield increasing of patchouli oils of result steam distillation of patchouli leaf of dewaxing, fermentation, and drying process,” Journal Basic Science and Technology, vol. 1, no. 3, pp. 12–18, 2012. View at Google Scholar
  2. S. J. Raharjo and F. Fatchiyah, “Virtual screening of compounds from the patchouli oil of Pogostemon herba for COX-1 inhibition,” Bioinformation, vol. 9, no. 6, pp. 321–324, 2013. View at Publisher · View at Google Scholar
  3. Y.-C. Li, S.-Z. Peng, H.-M. Chen et al., “Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice,” International Immunopharmacology, vol. 12, no. 1, pp. 294–301, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-F. Xian, Y.-C. Li, S.-P. Ip, Z.-X. Lin, X.-P. Lai, and Z.-R. Su, “Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis herba in LPS-stimulated RAW264.7 macrophages,” Experimental and Therapeutic Medicine, vol. 2, no. 3, pp. 545–550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. E. Furse, D. A. Pratt, N. A. Porter, and T. P. Lybrand, “Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior,” Biochemistry, vol. 45, no. 10, pp. 3189–3205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Dannhardt and S. Laufer, “Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore?” Current Medicinal Chemistry, vol. 7, no. 11, pp. 1101–1112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Perrone, A. Scilimati, L. Simone, and P. Vitale, “Selective COX-1 inhibition: a therapeutic target to be reconsidered,” Current Medicinal Chemistry, vol. 17, no. 32, pp. 3769–3805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. Raharjo, C. Mahdi, N. Nurdianan, W. Nellen, and F. Fatchiyah, “Patchouli alcohol isomers pogostemon herba predicted virtually,” Journal of Biological Researches, vol. 18, pp. 98–101, 2013. View at Google Scholar
  9. S. J. Raharjo, C. Mahdi, N. Nurdiana, and F. Fatchiyah, “Virtual screening sesquiterpenoid pogostemon Herba as novel COX-1/COX-2 inhibitor selective,” in Proceedings of the ICAST, Kumamoto, Japan, 2013.
  10. M. Rarey, B. Kramer, T. Lengauer, and G. Klebe, “A fast flexible docking method using an incremental construction algorithm,” Journal of Molecular Biology, vol. 261, no. 3, pp. 470–489, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Azam and S. W. Abbasi, “Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines,” Theoretical Biology and Medical Modelling, vol. 10, no. 1, article 63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. K. Haider, H.-O. Bertrand, and R. E. Hubbard, “Predicting fragment binding poses using a combined MCSS MM-GBSA approach,” Journal of Chemical Information and Modeling, vol. 51, no. 5, pp. 1092–1105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Kurumbail, A. M. Stevens, J. K. Gierse et al., “Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents,” Nature, vol. 384, no. 19–26, pp. 644–648, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Lovell, I. W. Davis, W. B. Arendall III et al., “Structure validation by Cα geometry: φ,ψ and Cβ deviation,” Proteins: Structure, Function and Genetics, vol. 50, no. 3, pp. 437–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Uciechowska, J. Schemies, M. Scharfe et al., “Binding free energy calculations and biological testing of novel thiobarbiturates as inhibitors of the human NAD+ dependent histone deacetylase Sirt2,” MedChemComm, vol. 3, no. 2, pp. 167–173, 2012. View at Publisher · View at Google Scholar
  16. R. Pouplana, J. J. Lozano, and J. Ruiz, “Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2),” Journal of Molecular Graphics and Modelling, vol. 20, no. 4, pp. 329–343, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Goodsell, “The molecular perspective: cyclooxygenase-2,” Stem Cells, vol. 18, no. 3, pp. 227–229, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Simmons, R. M. Botting, and T. Hla, “Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition,” Pharmacological Reviews, vol. 56, no. 3, pp. 387–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Wan and P. V. Coveney, “A comparative study of the COX-1 and COX-2 isozymes bound to lipid membranes,” Journal of Computational Chemistry, vol. 30, no. 7, pp. 1038–1050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Campanera and R. Pouplana, “MMPBSA decomposition of the binding energy throughout a molecular dynamics simulation of amyloid-beta (Abeta10–35) aggregation,” Molecules, vol. 15, no. 4, pp. 2730–2748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Srivastava, V. K. Singh, B. D. Singh, G. Srivastava, B. B. Misra, and V. Tripathi, “Screening and identification of salicin compound from Desmodium gangeticum and its in vivo anticancer activity and docking studies with cyclooxygenase (COX) proteins from mus musculus,” Journal of Proteomics & Bioinformatics, vol. 6, no. 5, pp. 109–124, 2013. View at Publisher · View at Google Scholar · View at Scopus